Benhao Li
Overview
Explore the profile of Benhao Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
736
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang S, Li W, Li B, Chen S, Lei S, Liu Y, et al.
J Med Chem
. 2025 Jan;
68(3):3324-3334.
PMID: 39878298
Endowing cyanine dyes with hydrophilicity, long blood circulation, tumor targeting, and robust therapeutic efficacy in the second near-infrared (NIR-II) window is challenging for cancer treatment. Herein, we develop cancer cell...
2.
Zhang M, Wang Y, Li B, Yang B, Zhao M, Li B, et al.
Adv Mater
. 2024 Dec;
37(10):e2412654.
PMID: 39713955
The unprecedented success of mRNA vaccines against COVID-19 has inspired scientists to develop mRNA vaccines for cancer immunotherapy. However, using nucleoside modified mRNA as vaccine, though evading innate immune toxicity,...
3.
Li B, Liu H, Zhao M, Zhang X, Huang P, Chen X, et al.
Angew Chem Int Ed Engl
. 2024 May;
63(31):e202404093.
PMID: 38727540
Accurate visualization of tumor microenvironment is of great significance for personalized medicine. Here, we develop a near-infrared (NIR) fluorescence/photoacoustic (FL/PA) dual-mode molecular probe (denoted as NIR-CE) for distinguishing tumors based...
4.
Zhao M, Lai W, Li B, Bai T, Liu C, Lin Y, et al.
Angew Chem Int Ed Engl
. 2024 Apr;
63(26):e202403968.
PMID: 38637949
Fluorescence sensing is crucial to studying biological processes and diagnosing diseases, especially in the second near-infrared (NIR-II) window with reduced background signals. However, it's still a great challenge to construct...
5.
Liu L, Li B, Wang P
Front Bioeng Biotechnol
. 2023 Sep;
11:1267302.
PMID: 37711446
No abstract available.
6.
Zhang Y, Chen P, Li B, Guo H, Zhu J, Dang Z, et al.
ACS Nano
. 2023 Aug;
17(17):16743-16756.
PMID: 37616516
Chemodynamic therapy (CDT) is a highly tumor-specific treatment, while its efficacy is compromised by the intratumoral Fenton reaction efficiency, which is determined by the following reaction factors, including the availability...
7.
Li B, Zhao M, Lai W, Zhang X, Yang B, Chen X, et al.
Angew Chem Int Ed Engl
. 2023 Apr;
62(25):e202302676.
PMID: 37074038
Endosomal escape remains a central issue limiting the high protein expression of mRNA therapeutics. Here, we present second near-infrared (NIR-II) lipid nanoparticles (LNPs) containing pH activatable NIR-II dye conjugated lipid...
8.
Zhao M, Zhuang H, Li B, Chen M, Chen X
Adv Mater
. 2023 Mar;
35(20):e2209944.
PMID: 36856448
In vivo cross-linking of nanoparticles is widely used to increase accumulation of therapeutic agents at tumor site for enhanced therapy. However, the components in nanoplatforms usually only play for one...
9.
Huang P, Jiang L, Pan H, Ding L, Zhou B, Zhao M, et al.
Adv Mater
. 2022 Nov;
35(3):e2207471.
PMID: 36326183
Among the few available mRNA delivery vehicles, lipid nanoparticles (LNPs) are the most clinically advanced but they require cumbersome four components and suffer from inflammation-related side effects that should be...
10.
Zhao M, Zhuang H, Zhang H, Li B, Ming J, Chen X, et al.
Angew Chem Int Ed Engl
. 2022 Sep;
61(47):e202209592.
PMID: 36175373
Designing luminescence lifetime sensors in the second near-infrared (NIR-II) window is a great challenge due to the difficult structural construction. Here, we report a tumor redox responsive and easily synthesized...